- Home
- / Miromatrix
Miromatrix
Revenue
$953.5 K
FY, 2022
Miromatrix Summary
Company Summary
- Overview
- Miromatrix Medical is a biotechnology company that develops transplantable human organs. It uses perfusion decellularization and recellularization technology to engineer livers and kidneys. The company also develops a bioengineered external liver assist device for acute liver failure.
- Type
- Subsidiary
- Status
- Active
- Founded
- 2009
- HQ
- Eden Prairie, MN, US | view all locations
- Website
- https://www.miromatrix.com/
- Cybersecurity rating
Table of Contents
Key People
Brian Niebur, Chief Financial Officer
M Mason Macenski, Vice President Clinical & Regulatory Affairs
LocationsView all
1 location detected
Eden Prairie, MN HQ
United States
6455 Flying Cloud Dr
Miromatrix Financials
Summary Financials
- Revenue (Q3, 2023)
- $11.2K
- Gross profit (Q3, 2023)
- ($113.8K)
- Net income (Q3, 2023)
- ($6.5M)
- Cash (Q3, 2023)
- $6.1M
- EBIT (Q3, 2023)
- ($6.6M)